ALPHAPORT.AI
🇺🇸HealthLynked CorpHLYK
USDUSD
SectorHealth CareIndustryProviders
Management
Michael Thomas Dent M.D.
CEO

Company information

Ticker
HLYK
Country
United States
Sector
Health Care
Industry
Providers

HealthLynked Business Summary

HealthLynked Corp (HLYK) operates a diversified healthcare technology ecosystem generating revenue through a mix of recurring subscription fees, transaction-based medical supply sales, and clinical service fees. The company is organized into three primary segments: Health Services, which manages physical clinics like the Naples Women’s Center; Digital Healthcare, centered on the HealthLynked Network and its proprietary AI-driven assistant, ARI; and Medical Distribution, which facilitates e-commerce via the MedOfficeDirect Shopify platform. By leveraging a Per Member Per Month (PMPM) model for payer partnerships and a cloud-based patient-centric record system, HealthLynked aims to reduce care coordination costs and improve patient outcomes. In the competitive landscape, the company contends with established electronic health record (EHR) and telehealth giants such as Veradigm, Athenahealth, Epic Systems, and Zocdoc. HealthLynked distinguishes itself as a niche, AI-integrated infrastructure provider currently transitioning from the OTCQB to a planned Nasdaq Capital Market listing to scale its national footprint. The leadership team is anchored by Founder, CEO, and Chairman Dr. Michael T. Dent, M.D., a serial entrepreneur who previously founded NeoGenomics Laboratories, a multi-billion dollar oncology diagnostics firm. Supporting the company’s 2026 expansion and Nasdaq uplisting strategy are Chief Operating Officer Duncan McGillivray, who joined in late 2025 with over 30 years of healthcare finance expertise, and Chief Financial Officer Jeremy Daniel, a CPA with a background in high-growth biotech acquisitions. The technology roadmap is led by Chief Technology and Product Officer Andrew Mavliev, formerly the founding CTO of the ToYou super-app. The company’s governance was recently bolstered by the appointment of insurance veterans Chris G. Pulos of Marsh McLennan and Jason Bishara of NSI Insurance to the Board of Directors. Dr. Dent remains a pivotal stakeholder and primary financier, recently consolidating over $5.7 million in company debt into a secured convertible note to stabilize the balance sheet ahead of its public offering.

Updated 2026-07-31 · US SEC company filings
Financial Metric TrendsQuarterly⌄
Business Overview is available publicly. Financials, KPIs, reports, transcripts and the rest of Research require the Research tier.